Skip to content

Food and Drug Recall.org

The Latest Food & Drug Recall and Safety News

FDA approves Ibrance for postmenopausal women with advanced breast cancer

February 3, 2015Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin

The U.S. Food and Drug Administration today granted accelerated approval to Ibrance (palbociclib) to treat advanced (metastatic) breast cancer.

Post navigation

← The Spice Mill issues Allergy Alert on Undeclared Peanut Protein in Ground Cumin and Cajun Seasoning Products Whole Foods Market Recalls Raw Macadamia Nuts from Stores in AL, GA, MS, NC, SC and TN Due to Possible Health Risk →
Proudly powered by WordPress